American Research & Management Co. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
American Research & Management Co. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2022$26,000
-7.1%
2,0000.0%0.01%0.0%
Q2 2022$28,000
-3.4%
2,0000.0%0.01%
+16.7%
Q1 2022$29,000
+7.4%
2,0000.0%0.01%0.0%
Q4 2021$27,000
-18.2%
2,0000.0%0.01%
-25.0%
Q3 2021$33,000
-2.9%
2,0000.0%0.01%0.0%
Q2 2021$34,000
-8.1%
2,0000.0%0.01%
-11.1%
Q1 2021$37,000
+2.8%
2,0000.0%0.01%0.0%
Q4 2020$36,0000.0%2,0000.0%0.01%
-18.2%
Q3 2020$36,0000.0%2,0000.0%0.01%0.0%
Q2 2020$36,000
+20.0%
2,0000.0%0.01%0.0%
Q1 2020$30,000
+2900.0%
2,000
+3233.3%
0.01%
Q4 2019$1,000
-93.3%
60
-91.9%
0.00%
-100.0%
Q1 2019$15,0007450.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders